Literature DB >> 12835545

Dermatological and ophthalmological sequels in toxic epidermal necrolysis.

S Magina1, C Lisboa, V Leal, J Palmares, J Mesquita-Guimarães.   

Abstract

BACKGROUND: Toxic epidermal necrolysis (TEN) is a rare, drug-induced disease characterized by epidermal detachment and mucosal involvement. After an acute period, potentially disabling cutaneous and ocular sequels may appear. Although long-term complications are not rare, only few outcome studies are published.
OBJECTIVE: To evaluate the incidence of dermatological and ophthalmological sequels following TEN, to describe its clinical aspects and correlation with acute involvement. PATIENTS AND METHODS: Eight patients surviving to TEN were submitted to dermatological and ophthalmological observation ranging from 0.5 to 8 years after hospitalization. Cutaneous and ocular involvement, during the acute phase, was retrospectively analysed.
RESULTS: Dermatological sequels were observed in 6 patients (75%) corresponding to those with more extensive skin involvement in the acute phase. The most frequent complications were cutaneous dyschromia (62.5%) and nail dystrophies (37.5%). Six patients (75%) had ocular complications with tarsal conjunctiva keratinization in 5 (62.5%) and keratoconjunctivitis sicca in 4 of them (50%). Trichiasis, corneal neovascularization and symblepharon were observed in 1 case. There was no correlation between the severity of acute ocular involvement and long-term complications.
CONCLUSION: Following TEN, most patients have dermatological and ophthalmological sequels that persist for several years. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12835545     DOI: 10.1159/000070938

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  14 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  [Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin].

Authors:  P Spornraft-Ragaller; H Theilen; G S Gottschlich; M Ragaller
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

3.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  Clinical Characteristics of Patients With Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom.

Authors:  Samir Jabbour; Nizar Din; Abison Logeswaran; Sara Taberno Sanchez; Sajjad Ahmad
Journal:  Front Med (Lausanne)       Date:  2021-05-24

5.  The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease.

Authors:  Leangelo N Hall; Swapna S Shanbhag; Ramy Rashad; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-05-20       Impact factor: 5.033

Review 6.  Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Authors:  Thomas Harr; Lars E French
Journal:  Orphanet J Rare Dis       Date:  2010-12-16       Impact factor: 4.123

Review 7.  Toxic epidermal necrolysis.

Authors:  Wolfram Hoetzenecker; Tarun Mehra; Ieva Saulite; Martin Glatz; Peter Schmid-Grendelmeier; Emmanuella Guenova; Antonio Cozzio; Lars E French
Journal:  F1000Res       Date:  2016-05-20

Review 8.  Treatments for Severe Cutaneous Adverse Reactions.

Authors:  Yung-Tsu Cho; Chia-Yu Chu
Journal:  J Immunol Res       Date:  2017-12-27       Impact factor: 4.818

Review 9.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

Review 10.  Phenytoin-induced toxic epidermal necrolysis: Review and recommendations.

Authors:  Osama M Al-Quteimat
Journal:  J Pharmacol Pharmacother       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.